荣昌生物涨5% 无CDMO业务计划

智选洞察2025-04-21

04月21日，荣昌生物（688331）股价大幅上涨，截至10点22分，荣昌生物上涨5.03%，报47.39元/股，成交1.00亿元，换手率1.34%，振幅6.12%。消息解读荣昌生物在互动平台表示，公司目前没有开展CDMO业务的计划；对于国际BD的谈判，公司将会根据进展情况，严格按照相关法律法规，及时履行信息披露义务。。此外，数据统计显示，近半年内6家券商给予买入建议，3家券商给予中性建议。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2529081270?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-21 10:22","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2529081270","market":"sh","top_or_hot":-1,"title":"荣昌生物涨5% 无CDMO业务计划","media":"智选洞察","content":"<div>\n<p>04月21日，荣昌生物（688331）股价大幅上涨，截至10点22分，荣昌生物上涨5.03%，报47.39元/股，成交1.00亿元，换手率1.34%，振幅6.12%。消息解读荣昌生物在互动平台表示，公司目前没有开展CDMO业务的计划；对于国际BD的谈判，公司将会根据进展情况，严格按照相关法律法规，及时履行信息披露义务。  。此外，数据统计显示，近半年内6家券商给予买入建议，3家券商给予中性建议。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421102351a46060dc&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>荣昌生物涨5% 无CDMO业务计划</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n荣昌生物涨5% 无CDMO业务计划\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-21 10:22 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421102351a46060dc&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>04月21日，荣昌生物（688331）股价大幅上涨，截至10点22分，荣昌生物上涨5.03%，报47.39元/股，成交1.00亿元，换手率1.34%，振幅6.12%。消息解读荣昌生物在互动平台表示，公司目前没有开展CDMO业务的计划；对于国际BD的谈判，公司将会根据进展情况，严格按照相关法律法规，及时履行信息披露义务。  。此外，数据统计显示，近半年内6家券商给予买入建议，3家券商给予中性建议。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421102351a46060dc&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1064130708.USD","symbol_name":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421102351a46060dc&s=b","article_id":"2529081270","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421102351a46060dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2529081270","pubTimestamp":1745202154,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"04月21日，荣昌生物股价大幅上涨，截至10点22分，荣昌生物上涨5.03%，报47.39元/股，成交1.00亿元，换手率1.34%，振幅6.12%。消息解读荣昌生物在互动平台表示，公司目前没有开展CDMO业务的计划；对于国际BD的谈判，公司将会根据进展情况，严格按照相关法律法规，及时履行信息披露义务。资金动向截止发稿，荣昌生物获得主力净流入605万元，其中超大单流入592万元，大单流入12万元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688331":"荣昌生物","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","BK0239":"医药制造"},"translate_title":"Rongchang Biotech rose 5% without CDMO business plan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688331":1},"content_text":"04月21日，荣昌生物（688331）股价大幅上涨，截至10点22分，荣昌生物上涨5.03%，报47.39元/股，成交1.00亿元，换手率1.34%，振幅6.12%。消息解读荣昌生物在互动平台表示，公司目前没有开展CDMO业务的计划；对于国际BD的谈判，公司将会根据进展情况，严格按照相关法律法规，及时履行信息披露义务。  。此外，数据统计显示，近半年内6家券商给予买入建议，3家券商给予中性建议。资金动向截止发稿，荣昌生物获得主力净流入605万元，其中超大单流入592万元，大单流入12万元。数据显示，该股今日净流入较近5日净流入均值增加750万元。主营业务及业绩荣昌生物公司主营业务为公司是一家具有全球化视野的创新型生物制药企业，自成立以来一直专注于抗体药物偶联物(ADC)、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。公司致力于发现、开发与商业化创新、有特色的同类首创(first-in-class)与同类最佳(best-in-class)生物药，以创造药物临床价值为导向，为自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域提供安全、有效、可及的临床解决方案，以满足大量尚未被满足的临床需求。最新财报显示，今年年报，荣昌生物实现营业收入17.17亿元，同比增长58.54%，净利润为-14.68亿元，同比增长2.84%，基本每股收益为-2.73元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2529081270","isCrawlerRequest":true}